{"id":11457,"date":"2022-07-01T20:38:32","date_gmt":"2022-07-02T00:38:32","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/2020-frontiers-in-cancer-immunotherapy\/"},"modified":"2022-07-14T13:21:32","modified_gmt":"2022-07-14T17:21:32","slug":"2020-frontiers-in-cancer-immunotherapy","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/2020-frontiers-in-cancer-immunotherapy","title":{"rendered":"2020 Frontiers in Cancer Immunotherapy"},"content":{"rendered":"<p>This annual two-day meeting convenes top experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response. Key topics under discussion this year include tumor evolution, neoantigens, novel therapeutic targets, and mechanisms driving the emergence of resistance to current therapy.<\/p>\n<p><b>FEATURED SPEAKERS<\/b>:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.cancerresearch.org\/scientific-advisory-council\/elizabeth-m-jaffee\">Elizabeth Jaffee, MD<\/a>, Johns Hopkins School of Medicine<\/li>\n<li>Elaine Mardis, PhD, The Ohio State University<\/li>\n<li><a href=\"https:\/\/www.cancerresearch.org\/scientific-advisory-council\/robert-d-schreiber\">Robert Schreiber, PhD<\/a>, Washington University School of Medicine in St. Louis<\/li>\n<li>Charles Swanton, FRCP, PhD, FRS, The Francis Crick Institute<\/li>\n<li>Catherine Wu, MD, Dana-Farber Cancer Institute and Harvard Medical School<\/li>\n<\/ul>\n<p><b>ABSTRACT DEADLINE<\/b>: March 3, 2020<\/p>\n<p><b>REGISTER<\/b>: <a href=\"https:\/\/www.nyas.org\/events\/2020\/frontiers-in-cancer-immunotherapy-2020\/\" target=\"_blank\" rel=\"noopener\">nyas.org\/Immunotherapy2020<\/a><\/p>\n<p><strong>Early Bird Discount Ends: <\/strong>March 30, 2020<\/p>\n<p>May 11-12, 2020, at the New York Academy of Sciences in New York City<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The New York Academy of Sciences annual two-day meeting convenes top experts in tumor immunology, cancer genetics and computational biology.<\/p>\n","protected":false},"featured_media":2232,"template":"","events_categories":[199],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11457","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-conferences"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2020 Frontiers in Cancer Immunotherapy<\/title>\n<meta name=\"description\" content=\"This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2020 Frontiers in Cancer Immunotherapy\" \/>\n<meta property=\"og:description\" content=\"This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T17:21:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3d3a50d7-69db-4b1d-a40d-1f9a3914dd8b.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"2020 Frontiers in Cancer Immunotherapy\" \/>\n<meta name=\"twitter:description\" content=\"This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3d3a50d7-69db-4b1d-a40d-1f9a3914dd8b.png\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy\",\"name\":\"2020 Frontiers in Cancer Immunotherapy\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/409d414a-627e-44f6-af11-b6079962d9e3.jpg\",\"datePublished\":\"2022-07-02T00:38:32+00:00\",\"dateModified\":\"2022-07-14T17:21:32+00:00\",\"description\":\"This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/409d414a-627e-44f6-af11-b6079962d9e3.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/409d414a-627e-44f6-af11-b6079962d9e3.jpg\",\"width\":700,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"2020 Frontiers in Cancer Immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2020 Frontiers in Cancer Immunotherapy","description":"This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy","og_locale":"es_ES","og_type":"article","og_title":"2020 Frontiers in Cancer Immunotherapy","og_description":"This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response.","og_url":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T17:21:32+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3d3a50d7-69db-4b1d-a40d-1f9a3914dd8b.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"2020 Frontiers in Cancer Immunotherapy","twitter_description":"This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/3d3a50d7-69db-4b1d-a40d-1f9a3914dd8b.png","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy","url":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy","name":"2020 Frontiers in Cancer Immunotherapy","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/409d414a-627e-44f6-af11-b6079962d9e3.jpg","datePublished":"2022-07-02T00:38:32+00:00","dateModified":"2022-07-14T17:21:32+00:00","description":"This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/409d414a-627e-44f6-af11-b6079962d9e3.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/409d414a-627e-44f6-af11-b6079962d9e3.jpg","width":700,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/2020-frontiers-in-cancer-immunotherapy#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"2020 Frontiers in Cancer Immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/2232"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11457"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11457"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11457"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11457"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11457"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11457"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}